News
STROKE AF at 3 years: High AFib rate after atherosclerotic stroke
Continuous monitoring to detect AFib should be considered in a larger population of stroke patients rather than just those with cryptogenic stroke...
News
Brain differences suggest therapeutic targets in Takotsubo
A new study has identified differences in the brain between patients with Takotsubo syndrome, a cardiomyopathy triggered by intense emotional...
News
Warfarin best for thrombotic antiphospholipid syndrome?
A vitamin K antagonist such as warfarin, rather than a direct oral anticoagulant, appears to be a better treatment for patients with thrombotic...
News
Is thrombolysis safe for stroke patients on DOACs?
“Our results suggest that current guidelines need to be revised to remove the absolute contraindication of thrombolysis in patients on DOACs.”
News
Cardiac injury caused by COVID-19 less common than thought
Study examines cardiac MRI scans in 31 patients before and after having COVID-19.
News
‘Reassuring’ data on pregnancy with ischemic heart disease
The risk associated with isolated preexisting ischemic heart disease without additional evidence of cardiomyopathy was relatively similar to that...
News
The 'Plaque Hypothesis': Focus on vulnerable lesions to cut events
A new strategy is needed that targets unstable plaque in the whole of the coronary arteries, rather than just obstructive lesions, to reduce major...
News
Chlorthalidone, HCTZ equally effective in hypertension: DCP published
The Diuretic Comparison Project trial, showing no difference in clinical events between diuretics chlorthalidone and hydrochlorothiazide for...
News
Statins tied to lower ICH risk regardless of bleed location
A large new case-control study has shown a reduced risk of both lobar and nonlobar intracerebral hemorrhage with statin use, providing reassurance...
News
Analysis suggests CV benefits for some antioxidant supplements
“Identifying the optimal mixture of micronutrients is important, as not all are beneficial.”
News
Lp(a) tied to more early CV events than familial hypercholesterolemia
Higher levels of lipoprotein(a) are associated with risk similar to that seen with familial hypercholesterolemia, but with risk starting as low as...
News
No benefit of rivaroxaban in COVID outpatients: PREVENT-HD
PREVENT-HD joins a long list of smaller trials also showing no benefit of anticoagulation in nonhospitalized COVID-19 patients.
News
Four-drug combo gets BP down in one step: QUARTET-USA
The combination product containing quarter doses of four different drugs reduced blood pressure by almost 5 mm Hg more than a standard dose of one...
News
New trial suggests CV benefit with EPA: RESPECT-EPA
The open-label trial could add some support to findings from the REDUCE-IT study, which showed a reduction in cardiovascular events with high-dose...
News
Diuretic agents equal to prevent CV events in hypertension: DCP
Cardiovascular events were nearly identical with two different hypertension drugs in the randomized Diuretic Comparison Project trial.